Attached files

file filename
10-K - 10-K - ELITE PHARMACEUTICALS INC /NV/v316806_10k.htm
EXCEL - IDEA: XBRL DOCUMENT - ELITE PHARMACEUTICALS INC /NV/Financial_Report.xls
EX-23 - EXHIBIT 23 - ELITE PHARMACEUTICALS INC /NV/v316806_ex23.htm
EX-21 - EXHIBIT 21 - ELITE PHARMACEUTICALS INC /NV/v316806_ex21.htm
EX-32.2 - EXHIBIT 32.2 - ELITE PHARMACEUTICALS INC /NV/v316806_ex32-2.htm
EX-31.2 - EXHIBIT 31.2 - ELITE PHARMACEUTICALS INC /NV/v316806_ex31-2.htm
EX-10.77 - EXHIBIT 10.77 - ELITE PHARMACEUTICALS INC /NV/v316806_ex10-77.htm
EX-31.1 - EXHIBIT 31.1 - ELITE PHARMACEUTICALS INC /NV/v316806_ex31-1.htm

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Elite Pharmaceuticals, Inc. (the “Company”) on Form 10-K for the year ended March 31, 2012 filed with Securities and Exchange Commission (the “Report”), I, Jerry Treppel, Chairman of the Board of Directors and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and
2.The information contained in the Report fairly presents, in all material respects, the consolidated financial condition of the Company as of the dates presented and the consolidated result of operations of the Company for the periods presented.

 

Date: June 29, 2012   /s/ Jerry Treppel  
    Jerry Treppel, Chairman of the Board and Chief Executive Officer

 

This certification has been furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

A signed original of this written statement required by Section 906 has been provided to Elite Pharmaceuticals, Inc. and will be retained by Elite Pharmaceuticals Inc. and furnished to the Securities and Exchange Commission or its staff upon request.